Welcome to the New Nuclear Medicine Technologist Section, providing you access to everything you need on the SNMMI website in one place.
The nuclear medicine and molecular imaging technologists are highly specialized healthcare professionals who works closely with the nuclear medicine physician. Some of the technologist’s primary responsibilities are to: Prepare and administer radioactive chemical compounds, known as radiopharmaceuticals and to administer adjunctive medications in order to perform patient imaging procedures using sophisticated instrumentation; Process data and enhance digital images using advanced computer technology; Provide images, data analysis, and patient information to the physician for diagnostic interpretation; and Evaluate new procedures for appropriateness in specific clinical settings and patient populations.
The Society of Nuclear Medicine and Molecular Imaging Technologist Section as part of the SNMMI, is constantly striving to make a difference in the way nuclear medicine and molecular imaging technologists receive academic and continuing education as well as information concerning new procedures, technologies and equipment. Research has been a vital part of SNMMI-TS activities for many years, as has monitoring federal regulation and influencing decisions that affect the practice of nuclear medicine.
In addition to providing discussion forums and publishing journals, newsletters and books, SNMMI-TS also sponsors international meetings and workshops designed to increase the competencies of nuclear medicine practitioners and to promote new scientific advances. The activities of the SNMMI-TS National Council of Representatives, volunteer committee members, and staff focus on improving the quality of care for the patients served by technologists around the world.
Learn more about Nuclear Medicine and Molecular Imaging Technologists.
SNMMI educational programs are designed to meet the professional development needs of technologists in the field of nuclear medicine and molecular imaging, as well as providing them with continuing education credit opportunities. SNMMI is an ARRT-recognized conitinuing education mechanism (RCEEMs) provider through the Society's Verification Of Involvement in Continuing Education (VOICE) program.
The PET Online Review Workshop is designed to help prepare technologists for the NMTCB's PET Exam. Following the NMTCB's content outline, the workshop offers a comprehensive review of both PET and PET/CT.
The NCT (Nuclear Cardiology Technologist) Online Review Workshop is designed to prepare technologists for the NMTCB's NCT Exam. The course reviews the NMTCB's nuclear cardiology examination content specifications.
Introducing a new member-benefit. Stay on top of the latest trends and advancements in the profession with quarterly technologist-focused webinars—free for SNMMI-TS members.
The profession of nuclear medicine and molecular imaging has evolved over the past several years, and continues to evolve to include imaging and therapy beyond the sole use of radioactive materials. Fusion imaging, combining traditional nuclear medicine with other imaging technologies like CT and MRI and their related contrast agents, as well as new and exciting areas like fluorescence imaging are examples of this. ‘Molecular imaging and therapy’ is a phrase which has been developed in recognition of this expansion. As such, the SNMMI-TS has embraced this evolution with a vision of being the recognized leader in this exciting and ever-growing arena.
The SNMMI-TS offers several professional advancement opportunities, including the SNMMI-TS Leadership Academy and Porfessional Development Awards and Scholarships. Learn more.
In addition, there are several advanced degree programs and certifications available to the nuclear medicine technologist. Specific areas include; the Nuclear Medicine Advanced Associate (masters degree and certification), PET Certification Exam, CT Certification Exam and NCT Certification Exam. Learn more about these and other opportunities.
The spectrum of responsibilities for a nuclear medicine technologist varies widely across the United States. Practice components presented in this document provide a basis for establishing the areas of knowledge and performance for the nuclear medicine technologist. The nuclear medicine technologist must be in compliance with all federal, state, and institutional guidelines, including proper documentation of initial and continued competency in those practices and activities.
Continuing education is a necessary component in maintaining the skills required to perform all duties and tasks of the nuclear medicine technologist in this ever-evolving field.
The Nuclear Medicine Technologist Scope of Practice and Performance Standards document is intended to set forth the standards in important areas of the nuclear medicine technologist’s responsibilities. It may not cover all areas which may present themselves in actual practice. These standards do not supersede the judgment of the individual nuclear medicine technologist and other healthcare professionals serving the patient in light of all of the facts of the individual case. THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING AND THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING TECHNOLOGIST SECTION DISCLAIM ALL LIABILITY ARISING FROM USE OF THESE DOCUMENTS.
The SNMMI-TS has a robust grants and awards program sponsored in part by the Education and Research Foundation (ERF). The numerous grants and awards offered spam from financial assistance for tuition for advanced degree programs, travel awards to attend the annual meeting, best abstract awards for abstracts presented during the annual meeting, clinical advancement awards and the leadership academy.
The SNMMI & SNMMI-TS Grants and Awards Committees are proud to announce that SNMMI has transitioned away from paper and will only be accepting online applications again in 2013!
Click here to learn more about all of the available SNMMI-TS awards and to review past award winners.
Visit SNMMI's Career Center.
Bracco Diagnostics Inc. announced that production is moving forward with targeted efforts for Kinevac commercial availability by the end of September.
(Government Relations News)
First-order treatment of cancer typically involves chemo and/or radiation therapy and surgical intervention, but radionuclide therapies offer some advantages for select patients by delivering a very intense dose sequestered to affected tumor sites. These are the therapies currently available and in clinical trials, with a few novel compounds waiting for validation in the wings.
(MI: Making a Difference)
Bioluminescence, nanoparticles, gene manipulation – these sound like the ideas of a science fiction writer, but, in fact, they are components of an exciting new approach to imaging local and metastatic tumors. In preclinical animal models of metastatic prostate cancer, scientists at Virginia Commonwealth University Massey Cancer Center, VCU Institute of Molecular Medicine and Johns Hopkins Medical Institutions have provided proof-of-principle of a new molecular imaging approach that could revolutionize doctors' ability to see tumors that have metastasized to other sites in the body, including the bones.
(MI: Making a Difference)
While guidelines recommend FDG-PET/CT only as an optional workup for women with stage III breast cancer, the hybrid modality can help women younger than 40 who have potentially aggressive stage II breast cancer, according to a study published online September 11 in the Journal of Nuclear Medicine.
(MI: Making a Difference)
Renew Your Membership!
Your Membership Expires:
September 30, 2014
Please take a moment to renew your SNMMI-TS membership for 2014-15 and maintain your commitment to excellence as you help guide the future of healthcare and personalized medicine.
*Please Note: Your membership year runs from October 1 to September 30, regardless of your join date.